Changing Paradigm for the Treatment of Advanced Renal Cell Cancer

Download Podcast

Listen to MP3

Podcast Evaluation

A presentation from the NCCN 2008 Nursing Program: Role of the Advanced Practice Nurse in Quality Oncology Care™ held in Hollywood, Florida.

Presenter

Carrie Silliman, MS, RN, FNP
Roswell Park Cancer Institute
Buffalo, New York

Faculty Disclosure Statement

Ms. Silliman has disclosed that she has no financial interests, arrangements, or affiliations with the manufacturer of any products or devices to be discussed in this activity or who may financially support the activity and has indicated that her presentation will not include discussion of investigational or unlabeled uses of commercial products.

Program Goal

The goal of this program is to provide advanced practice oncology nurses with information on changes in the treatment and management of patients with advanced renal cell carcinoma.

Educational Objectives

Following this activity, participants should be able to:

• Compare current therapy options for patients with advanced renal cell cancer
• Discuss the nursing considerations for patients receiving therapy for advanced renal cell cancer

Intended Audience

This educational activity is designed to meet the educational needs of advanced practice nurses who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statement prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A statement of credit will be electronically generated once you complete the evaluation form.  To receive credit, this activity must be completed no later than May 9, 2009.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

This activity is approved for 0.6 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  May 9, 2008
Expiration date:  May 9, 2009

Commercial Support

Supported by educational grants from Amgen, Eisai Inc., Eli Lilly and Company, Endo Pharmaceuticals, Merck Oncology, MGI PHARMA, INC., Novartis Oncology, and Pfizer Inc.